Remove 2025 Remove Drug Development Remove Health Technology
article thumbnail

Future HealthTech Valuations in 2025: A Dynamic Landscape

Lloyd Price

The increasing importance of digital health, coupled with abundant capital and supportive regulatory environments, is likely to drive continued M&A activity and higher valuations. In 2025, HealthTech valuations are expected to continue their upward trajectory, driven by several key factors: 1.

article thumbnail

HealthTech M&A 2025 Predictions: Europe and USA

Lloyd Price

Exec Summary: The HealthTech sector is poised for significant M&A activity in 2025, driven by several key trends: Digital Health Solutions: The increasing demand for digital health solutions to improve healthcare accessibility and efficiency will drive acquisitions of innovative startups and established players in this space.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Digital Health Technologies in Clinical Trials

Digital Health Global

Digital Health Technologies ( DHTs ) have revolutionized the landscape of clinical trials, particularly in neurology research, by enabling the collection of real-world data outside traditional clinical settings. in 2020, with projections suggesting up to 70% of clinical trials incorporating wearable sensors by 2025.

article thumbnail

B2C2B models gaining traction in HealthTech

Lloyd Price

In 2025, B2C2B models are poised to become increasingly prominent in healthcare, driven by several key factors: Digital Health Boom: The rapid growth of digital health technologies, such as telehealth, wearable devices, and AI-powered diagnostics, is creating new opportunities for B2C2B companies to reach both patients and healthcare providers.